Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 43 (8) , 613-620
- https://doi.org/10.1016/0753-3322(89)90040-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Tumor markers in non-malignant diseasesEuropean Journal of Cancer and Clinical Oncology, 1988
- The detection of colorectal carcinomas with the use of CA-50 radioimmunoassay inhibition testInternational Journal of Colorectal Disease, 1986
- New carbohydrate tumor markersGastroenterology, 1986
- Carcinoembryonic AntigenAnnals of Internal Medicine, 1986
- Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinomaGynecologic Oncology, 1985
- Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibodyFEBS Letters, 1985
- Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung.Thorax, 1985
- Serum Neuron-Specific EnolaseChest, 1985
- Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.BMJ, 1984
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981